Defining success in functional cure for chronic hepatitis B: a nationwide survey of physician benchmarks to guide clinical practice and trial design
Our findings translate the collective expertise of Chinese physicians into actionable benchmarks for HBV functional cure. The consensus on a minimal 30% cure rate and a preference for combination therapy provide crucial guidance for clinical trial design and the development of novel antiviral strategies.
Authors
- Yisi Liu (ORCID: https://orcid.org/0009-0000-7007-7693)
- Sujun Zheng
- Lina Ma
- X Y Chen
- S Ren
- Xiao Lin
- Junefeng Lu
Institutions
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/fpubh.2026.1707447
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Municipal Health Commission
- National Key Research and Development Program of China